Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
ASTRAZENECA PHARMACEUTICALS LP et al v. BIOVAIL LABORATORIES INTERNATIONAL SRL et al
Case Number:
3:09-cv-00128
Court:
Nature of Suit:
Judge:
Firms
- Connell Foley
- DLA Piper
- Fitzpatrick Cella
- Jackson Lewis PC
- McCarter & English
- McElroy Deutsch
- Stevens & Lee
- Walsh Pizzi
Companies
Sectors & Industries:
-
May 02, 2011
AstraZeneca Ends Seroquel Case Against Biovail
A New Jersey federal judge on Monday signed off on a joint stipulation of dismissal of AstraZeneca Pharmaceuticals LP’s case alleging Biovail Corp. infringed its patents by seeking to launch a generic version of AstraZeneca’s popular treatment for bipolar disorder and schizophrenia, Seroquel XR.
-
April 06, 2009
Biovail Fires Back At AstraZeneca In Seroquel IP Suit
Biovail Corp. has become the latest generics maker to ask a court to invalidate or rule unenforceable two patents for Seroquel XR — AstraZeneca Pharmaceuticals LP's popular treatment for bipolar disorder and schizophrenia — filing counterclaims that accuse the pharmaceutical giant of inequitable conduct.
-
January 13, 2009
AstraZeneca Slaps Biovail Over Seroquel XR
In its latest bid to protect two patents for Seroquel XR, AstraZeneca Pharmaceuticals LP has hit Biovail Corp. and two subsidiaries with an infringement suit over the popular treatment for bipolar disorder and schizophrenia.